Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors
- PMID: 16895736
- DOI: 10.1016/j.biomaterials.2006.07.015
Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors
Abstract
Human bone marrow contains a population of bone marrow stromal cells (hBMSCs) capable of forming several types of mesenchymal tissues, including bone and cartilage. The present study was designed to test whether large cartilaginous and bone-like tissue constructs can be selectively engineered using the same cell population (hBMSCs), the same scaffold type (porous silk) and same hydrodynamic environment (construct settling in rotating bioreactors), by varying the medium composition (chondrogenic vs. osteogenic differentiation factors). The hBMSCs were harvested, expanded and characterized with respect to their differentiation potential and population distribution. Passage two cells were seeded on scaffolds and cultured for 5 weeks in bioreactors using osteogenic, chondrogenic or control medium. The three media yielded constructs with comparable wet weights and compressive moduli ( approximately 25 kPa). Chondrogenic medium yielded constructs with higher amounts of DNA (1.5-fold) and glycosaminoglycans (GAG, 4-fold) per unit wet weight (ww) than control medium. In contrast, osteogenic medium yielded constructs with higher dry weight (1.6-fold), alkaline phosphatase (AP) activity (8-fold) and calcium content (100-fold) per unit ww than control medium. Chondrogenic medium yielded constructs that were weakly positive for GAG by contrast-enhanced MRI and alcian blue stain, whereas osteogenic medium yielded constructs that were highly mineralized by microCT and von Kossa stain. Engineered bone constructs were large (8mm diameter x 2mm thick disks) and resembled trabecular bone with respect to structure and mineralized tissue volume fraction (12%).
Similar articles
-
Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells.Biomaterials. 2006 Dec;27(36):6123-37. doi: 10.1016/j.biomaterials.2006.07.034. Epub 2006 Aug 30. Biomaterials. 2006. PMID: 16945410
-
Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors.J R Soc Interface. 2008 Aug 6;5(25):929-39. doi: 10.1098/rsif.2007.1302. J R Soc Interface. 2008. PMID: 18230586 Free PMC article.
-
Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor.J Biomed Mater Res. 2002 Oct;62(1):136-48. doi: 10.1002/jbm.10150. J Biomed Mater Res. 2002. PMID: 12124795
-
Modulation of cell differentiation in bone tissue engineering constructs cultured in a bioreactor.Adv Exp Med Biol. 2006;585:225-41. doi: 10.1007/978-0-387-34133-0_16. Adv Exp Med Biol. 2006. PMID: 17120788 Review.
-
An antibody based approach for multi-coloring osteogenic and chondrogenic proteins in tissue engineered constructs.Biomed Mater. 2018 Apr 11;13(4):044102. doi: 10.1088/1748-605X/aab51e. Biomed Mater. 2018. PMID: 29516869 Review.
Cited by
-
Bioreactor engineering of stem cell environments.Biotechnol Adv. 2013 Nov 15;31(7):1020-31. doi: 10.1016/j.biotechadv.2013.03.007. Epub 2013 Mar 24. Biotechnol Adv. 2013. PMID: 23531529 Free PMC article. Review.
-
PCL-forsterite nanocomposite fibrous membranes for controlled release of dexamethasone.J Mater Sci Mater Med. 2015 Jan;26(1):5364. doi: 10.1007/s10856-014-5364-4. Epub 2015 Jan 13. J Mater Sci Mater Med. 2015. PMID: 25578712
-
The effect of simulated microgravity on human mesenchymal stem cells cultured in an osteogenic differentiation system: a bioinformatics study.Tissue Eng Part A. 2010 Nov;16(11):3403-12. doi: 10.1089/ten.tea.2009.0834. Epub 2010 Aug 31. Tissue Eng Part A. 2010. PMID: 20807102 Free PMC article.
-
Silk fibroin/chitosan-hyaluronic acid versus silk fibroin scaffolds for tissue engineering: promoting cell proliferations in vitro.J Mater Sci Mater Med. 2010 Apr;21(4):1343-51. doi: 10.1007/s10856-009-3876-0. Epub 2010 Feb 5. J Mater Sci Mater Med. 2010. PMID: 20135206
-
Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols.Bonekey Rep. 2016 Oct 19;5:842. doi: 10.1038/bonekey.2016.75. eCollection 2016. Bonekey Rep. 2016. PMID: 27790370 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical